Mutual Advisors LLC Has $2.09 Million Stock Position in Axon Enterprise, Inc $AXON

Mutual Advisors LLC lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 669.4% during the third quarter, HoldingsChannel reports. The firm owned 2,916 shares of the biotechnology company’s stock after acquiring an additional 2,537 shares during the quarter. Mutual Advisors LLC’s holdings in Axon Enterprise were worth $2,089,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Brighton Jones LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $480,000. NewEdge Advisors LLC lifted its holdings in Axon Enterprise by 41.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company’s stock valued at $1,207,000 after purchasing an additional 668 shares during the last quarter. Empowered Funds LLC boosted its position in Axon Enterprise by 8.4% during the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company’s stock worth $1,067,000 after purchasing an additional 157 shares during the period. Woodline Partners LP boosted its position in Axon Enterprise by 40.6% during the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company’s stock worth $3,646,000 after purchasing an additional 2,003 shares during the period. Finally, Sivia Capital Partners LLC acquired a new position in shares of Axon Enterprise in the second quarter valued at $284,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Down 4.9%

NASDAQ AXON opened at $459.99 on Tuesday. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57. The company has a market cap of $36.30 billion, a price-to-earnings ratio of 145.57, a PEG ratio of 14.57 and a beta of 1.48. The company has a 50 day moving average of $577.05 and a 200-day moving average of $666.57. Axon Enterprise, Inc has a 1-year low of $459.50 and a 1-year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). The company had revenue of $710.64 million for the quarter, compared to the consensus estimate of $704.83 million. Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.Axon Enterprise’s revenue was up 30.6% on a year-over-year basis. During the same quarter last year, the business earned $1.45 EPS. On average, equities research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently commented on AXON. Wall Street Zen downgraded shares of Axon Enterprise from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Royal Bank Of Canada started coverage on shares of Axon Enterprise in a research report on Monday, November 17th. They set an “outperform” rating and a $860.00 price objective for the company. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research report on Monday, December 29th. Morgan Stanley lowered their target price on Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating on the stock in a research note on Wednesday, December 17th. Finally, UBS Group reduced their price target on Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating for the company in a research note on Wednesday, November 5th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $805.71.

Insider Activity at Axon Enterprise

In related news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $619.01, for a total value of $6,190,100.00. Following the transaction, the chief executive officer owned 3,100,997 shares in the company, valued at approximately $1,919,548,152.97. This trade represents a 0.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jeri Williams sold 100 shares of the business’s stock in a transaction dated Thursday, December 4th. The shares were sold at an average price of $550.63, for a total value of $55,063.00. Following the completion of the transaction, the director directly owned 1,316 shares of the company’s stock, valued at approximately $724,629.08. This trade represents a 7.06% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 60,540 shares of company stock worth $34,684,738 in the last quarter. 5.70% of the stock is currently owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.